Literature DB >> 29788038

Testing a longitudinal compensation model in premanifest Huntington's disease.

Sarah Gregory1,2, Jeffrey D Long3,4, Stefan Klöppel5,6, Adeel Razi2,7, Elisa Scheller6,8, Lora Minkova6,8, Eileanoir B Johnson1,9, Alexandra Durr10, Raymund A C Roos11, Blair R Leavitt12, James A Mills4, Julie C Stout13, Rachael I Scahill1,9, Sarah J Tabrizi1,9, Geraint Rees2,14.   

Abstract

The initial stages of neurodegeneration are commonly marked by normal levels of cognitive and motor performance despite the presence of structural brain pathology. Compensation is widely assumed to account for this preserved behaviour, but despite the apparent simplicity of such a concept, it has proven incredibly difficult to demonstrate such a phenomenon and distinguish it from disease-related pathology. Recently, we developed a model of compensation whereby brain activation, behaviour and pathology, components key to understanding compensation, have specific longitudinal trajectories over three phases of progression. Here, we empirically validate our explicit mathematical model by testing for the presence of compensation over time in neurodegeneration. Huntington's disease is an ideal model for examining longitudinal compensation in neurodegeneration as it is both monogenic and fully penetrant, so disease progression and potential compensation can be monitored many years prior to diagnosis. We defined our conditions for compensation as non-linear longitudinal trajectories of brain activity and performance in the presence of linear neuronal degeneration and applied our model of compensation to a large longitudinal cohort of premanifest and early-stage Huntington's disease patients from the multisite Track-On HD study. Focusing on cognitive and motor networks, we integrated progressive volume loss, task and resting state functional MRI and cognitive and motor behaviour across three sequential phases of neurodegenerative disease progression, adjusted for genetic disease load. Multivariate linear mixed models were fitted and trajectories for each variable tested. Our conceptualization of compensation was partially realized across certain motor and cognitive networks at differing levels. We found several significant network trends that were more complex than that hypothesized in our model. These trends suggest changes to our theoretical model where the network effects are delayed relative to performance effects. There was evidence of compensation primarily in the prefrontal component of the cognitive network, with increased effective connectivity between the left and right dorsolateral prefrontal cortex. Having developed an operational model for the explicit testing of longitudinal compensation in neurodegeneration, it appears that general patterns of our framework are consistent with the empirical data. With the proposed modifications, our operational model of compensation can be used to test for both cross-sectional and longitudinal compensation in neurodegenerative disease with similar patterns to Huntington's disease.

Entities:  

Mesh:

Year:  2018        PMID: 29788038      PMCID: PMC6022638          DOI: 10.1093/brain/awy122

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  25 in total

1.  Bivariate linear mixed models using SAS proc MIXED.

Authors:  Rodolphe Thiébaut; Hélène Jacqmin-Gadda; Geneviève Chêne; Catherine Leport; Daniel Commenges
Journal:  Comput Methods Programs Biomed       Date:  2002-11       Impact factor: 5.428

2.  Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data.

Authors:  Sarah J Tabrizi; Ralf Reilmann; Raymund A C Roos; Alexandra Durr; Blair Leavitt; Gail Owen; Rebecca Jones; Hans Johnson; David Craufurd; Stephen L Hicks; Christopher Kennard; Bernhard Landwehrmeyer; Julie C Stout; Beth Borowsky; Rachael I Scahill; Chris Frost; Douglas R Langbehn
Journal:  Lancet Neurol       Date:  2011-12-02       Impact factor: 44.182

3.  Dynamic causal modelling.

Authors:  K J Friston; L Harrison; W Penny
Journal:  Neuroimage       Date:  2003-08       Impact factor: 6.556

Review 4.  Efficiency, capacity, compensation, maintenance, plasticity: emerging concepts in cognitive reserve.

Authors:  Daniel Barulli; Yaakov Stern
Journal:  Trends Cogn Sci       Date:  2013-09-07       Impact factor: 20.229

Review 5.  Huntington's disease: from molecular pathogenesis to clinical treatment.

Authors:  Christopher A Ross; Sarah J Tabrizi
Journal:  Lancet Neurol       Date:  2011-01       Impact factor: 44.182

6.  Consistent neurodegeneration and its association with clinical progression in Huntington's disease: a coordinate-based meta-analysis.

Authors:  Imis Dogan; Simon B Eickhoff; Jörg B Schulz; N Jon Shah; Angela R Laird; Peter T Fox; Kathrin Reetz
Journal:  Neurodegener Dis       Date:  2012-08-23       Impact factor: 2.977

7.  Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data.

Authors:  Sarah J Tabrizi; Rachael I Scahill; Gail Owen; Alexandra Durr; Blair R Leavitt; Raymund A Roos; Beth Borowsky; Bernhard Landwehrmeyer; Chris Frost; Hans Johnson; David Craufurd; Ralf Reilmann; Julie C Stout; Douglas R Langbehn
Journal:  Lancet Neurol       Date:  2013-05-09       Impact factor: 44.182

8.  Diffeomorphic registration using geodesic shooting and Gauss-Newton optimisation.

Authors:  John Ashburner; Karl J Friston
Journal:  Neuroimage       Date:  2011-01-07       Impact factor: 6.556

9.  Prodromal Huntington disease as a model for functional compensation of early neurodegeneration.

Authors:  Kathrin Malejko; Patrick Weydt; Sigurd D Süßmuth; Georg Grön; Bernhard G Landwehrmeyer; Birgit Abler
Journal:  PLoS One       Date:  2014-12-26       Impact factor: 3.240

10.  Functional compensation of motor function in pre-symptomatic Huntington's disease.

Authors:  Stefan Klöppel; Bogdan Draganski; Hartwig R Siebner; Sarah J Tabrizi; Cornelius Weiller; Richard S J Frackowiak
Journal:  Brain       Date:  2009-04-15       Impact factor: 13.501

View more
  7 in total

1.  Interregional causal influences of brain metabolic activity reveal the spread of aging effects during normal aging.

Authors:  Xin Di; Marie Wölfer; Mario Amend; Hans Wehrl; Tudor M Ionescu; Bernd J Pichler; Bharat B Biswal
Journal:  Hum Brain Mapp       Date:  2019-08-07       Impact factor: 5.038

2.  Cortical Features in Child and Adolescent Carriers of Mutant Huntingtin (mHTT).

Authors:  Erin E Reasoner; Ellen van der Plas; Douglas R Langbehn; Amy L Conrad; Timothy R Koscik; Eric A Epping; Vincent A Magnotta; Peggy C Nopoulos
Journal:  J Huntingtons Dis       Date:  2022

Review 3.  Aberrant brain network connectivity in presymptomatic and manifest Huntington's disease: A systematic review.

Authors:  Lorenzo Pini; Charlotte Jacquemot; Annachiara Cagnin; Francesca Meneghello; Carlo Semenza; Dante Mantini; Antonino Vallesi
Journal:  Hum Brain Mapp       Date:  2019-09-18       Impact factor: 5.038

4.  Translational research on reserve against neurodegenerative disease: consensus report of the International Conference on Cognitive Reserve in the Dementias and the Alzheimer's Association Reserve, Resilience and Protective Factors Professional Interest Area working groups.

Authors:  Robert Perneczky; Gerd Kempermann; Amos D Korczyn; Fiona E Matthews; M Arfan Ikram; Nikolaos Scarmeas; Gael Chetelat; Yaakov Stern; Michael Ewers
Journal:  BMC Med       Date:  2019-02-27       Impact factor: 8.775

Review 5.  What is the Pathogenic CAG Expansion Length in Huntington's Disease?

Authors:  Jasmine Donaldson; Sophie Powell; Nadia Rickards; Peter Holmans; Lesley Jones
Journal:  J Huntingtons Dis       Date:  2021

6.  Association of specific biotypes in patients with Parkinson disease and disease progression.

Authors:  Linbo Wang; Wei Cheng; Edmund T Rolls; Fuli Dai; Weikang Gong; Jingnan Du; Wei Zhang; Shouyan Wang; Fengtao Liu; Jian Wang; Peter Brown; Jianfeng Feng
Journal:  Neurology       Date:  2020-08-14       Impact factor: 9.910

7.  Shape deformation analysis reveals the temporal dynamics of cell-type-specific homeostatic and pathogenic responses to mutant huntingtin.

Authors:  Myriam Heiman; Christian Neri; Lucile Megret; Barbara Gris; Satish Sasidharan Nair; Jasmin Cevost; Mary Wertz; Jeff Aaronson; Jim Rosinski; Thomas F Vogt; Hilary Wilkinson
Journal:  Elife       Date:  2021-02-23       Impact factor: 8.140

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.